Sustained and Localized Drug Depot Release using Radiation-Activated Scintillating Nanoparticles.
Adv Mater. 2024;:e2312326 - PMID: 38389502 - DOI: 10.1002/adma.202312326
Ocular Effects of MEK Inhibitor Therapy: Literature Review, Clinical Presentation, and Best Practices for Mitigation.
Oncologist. 2024;:ePub - PMID: 38527005 - DOI: 10.1093/oncolo/oyae014
2
CSV